Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy ; volume:22 ; number:1 ; day:3 ; month:7 ; year:2021 ; pages:1-9 ; date:12.2021
BMC immunology ; 22, Heft 1 (3.7.2021), 1-9, 12.2021
- Urheber
-
Ghaffari, Sasan
Torabi-Rahvar, Monireh
Aghayan, Sajjad
Jabbarpour, Zahra
Moradzadeh, Kobra
Omidkhoda, Azadeh
Ahmadbeigi, Naser
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12865-021-00435-7
- URN
-
urn:nbn:de:101:1-2021101322034382866103
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ghaffari, Sasan
- Torabi-Rahvar, Monireh
- Aghayan, Sajjad
- Jabbarpour, Zahra
- Moradzadeh, Kobra
- Omidkhoda, Azadeh
- Ahmadbeigi, Naser
- SpringerLink (Online service)
Ähnliche Objekte (12)
Adoptive T-cell therapy for Leukemia
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
The effect of endurance exercise on virus-specific cytotoxic T-cells for allogeneic adoptive T-cell immunotherapy
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
ARHGAP45 controls naïve T‐ and B‐ cell entry into lymph nodes and T‐cell progenitor thymus seeding
Adoptive T-cell therapy for Leukemia
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
The effect of endurance exercise on virus-specific cytotoxic T-cells for allogeneic adoptive T-cell immunotherapy
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
ARHGAP45 controls naïve T‐ and B‐ cell entry into lymph nodes and T‐cell progenitor thymus seeding
Adoptive T-cell therapy for Leukemia
CRISPR/Cas9 revitalizes adoptive T-cell therapy for cancer immunotherapy
Intracellular expression of FLT3 in Purkinje cells: implications for adoptive T-cell therapies
Adoptive T-cell-receptor transfer to examine human T-cell immunology in vitro
Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
Genetically-engineered T cells for adoptive T-cell therapy : from CARs to TRUCKs and beyond
Gene editing technology to improve antitumor T-cell functions in adoptive immunotherapy
A modified P450 Cytochrome as Safety Mechanism in Adoptive T-cell Therapy
High-intensity interval training in allogeneic adoptive T-cell immunotherapy – a big HIT?
The effect of endurance exercise on virus-specific cytotoxic T-cells for allogeneic adoptive T-cell immunotherapy
BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy